Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers

This study evaluated the tolerance and potential pharmacokinetic interactions between clarithromycin (500 mg every 12 h) and rifabutin (300 mg daily) in clinically stable human immunodeficiency virus-infected volunteers with CD4 counts of <200 cells/mm(3). Thirty-four subjects were randomized equall...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Hafner, Richard, Bethel, James, Power, Maureen, Landry, Bernard, Banach, Mary, Mole, Larry, Standiford, Harold C., Follansbee, Stephen, Kumar, Princy, Raasch, Ralph, Cohn, David, Mushatt, David, Drusano, George
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1998
Materias:	Pharmacology
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105510/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9517944/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.3.631
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!